135 related articles for article (PubMed ID: 9219761)
1. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients.
Del Brutto OH
J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):659-61. PubMed ID: 9219761
[TBL] [Abstract][Full Text] [Related]
2. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients.
Carpio A
J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):411-2. PubMed ID: 10084555
[No Abstract] [Full Text] [Related]
3. Albendazole therapy for giant subarachnoid cysticerci.
Del Brutto OH; Sotelo J; Aguirre R; Díaz-Calderón E; Alarcón TA
Arch Neurol; 1992 May; 49(5):535-8. PubMed ID: 1580817
[TBL] [Abstract][Full Text] [Related]
4. Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report.
del Brutto OH; Sotelo J
J Neurosurg; 1990 May; 72(5):816-7. PubMed ID: 2324806
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
Del Brutto OH; Roos KL; Coffey CS; García HH
Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
[TBL] [Abstract][Full Text] [Related]
6. Albendazole therapy for giant subarachnoid cysticerci.
Noboa C
Arch Neurol; 1993 Apr; 50(4):347-8. PubMed ID: 8460955
[No Abstract] [Full Text] [Related]
7. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.
Göngora-Rivera F; Soto-Hernández JL; González Esquivel D; Cook HJ; Márquez-Caraveo C; Hernández Dávila R; Santos-Zambrano J
Neurology; 2006 Feb; 66(3):436-8. PubMed ID: 16382035
[TBL] [Abstract][Full Text] [Related]
8. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.
Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E
Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213
[TBL] [Abstract][Full Text] [Related]
9. Albendazole therapy for neurocysticercosis.
Escobedo F; Penagos P; Rodriguez J; Sotelo J
Arch Intern Med; 1987 Apr; 147(4):738-41. PubMed ID: 3827462
[TBL] [Abstract][Full Text] [Related]
10. Albendazole therapy in orbital cysticercosis.
Srivastava VK; Srivastava A; Singhal KC
Indian J Physiol Pharmacol; 1996 Jul; 40(3):265-6. PubMed ID: 8950146
[TBL] [Abstract][Full Text] [Related]
11. Short course of albendazole therapy for neurocysticercosis.
Sotelo J; Penagos P; Escobedo F; Del Brutto OH
Arch Neurol; 1988 Oct; 45(10):1130-3. PubMed ID: 3178533
[TBL] [Abstract][Full Text] [Related]
12. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.
Garcia HH; Gilman RH; Horton J; Martinez M; Herrera G; Altamirano J; Cuba JM; Rios-Saavedra N; Verastegui M; Boero J; Gonzalez AE
Neurology; 1997 May; 48(5):1421-7. PubMed ID: 9153484
[TBL] [Abstract][Full Text] [Related]
13. [Neurocysticercosis in children: clinical and radiological analysis and prognostic factors in 54 patients].
del Brutto OH
Rev Neurol; 1997 Nov; 25(147):1681-4. PubMed ID: 9484517
[TBL] [Abstract][Full Text] [Related]
14. Albendazole in neurocysticercosis.
Padma MV; Behari M; Misra NK; Ahuja GK
Natl Med J India; 1995; 8(6):255-8. PubMed ID: 8520442
[TBL] [Abstract][Full Text] [Related]
15. The course of seizures after treatment for cerebral cysticercosis.
Vazquez V; Sotelo J
N Engl J Med; 1992 Sep; 327(10):696-701. PubMed ID: 1495522
[TBL] [Abstract][Full Text] [Related]
16. Intramedullary cysticercosis cured with drug treatment. A case report.
Corral I; Quereda C; Moreno A; López-Vélez R; Martínez-San-Millán J; Guerrero A; Sotelo J
Spine (Phila Pa 1976); 1996 Oct; 21(19):2284-7. PubMed ID: 8902977
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment of neurocysticercosis.
Garg RK
Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
[TBL] [Abstract][Full Text] [Related]
18. Failure of albendazole therapy in two common types of parenchymal neurocysticercosis.
Garg RK; Kar AM; Jain S
J Assoc Physicians India; 1995 Oct; 43(10):706-7. PubMed ID: 8773009
[No Abstract] [Full Text] [Related]
19. Fatty acids oxidation and alternative energy sources detected in Taenia crassiceps cysticerci after host treatment with antihelminthic drugs.
Fraga CM; Costa TL; Bezerra JC; de Souza Lino Junior R; Vinaud MC
Exp Parasitol; 2012 May; 131(1):111-5. PubMed ID: 22465501
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis.
Jung H; Hurtado M; Sanchez M; Medina MT; Sotelo J
J Clin Pharmacol; 1992 Jan; 32(1):28-31. PubMed ID: 1740534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
